US FDA’s Search For Class-Wide Vaccine Blood-Clot Effect Makes Scientific Sense, But Raises Questions

 
• By Derrick Gingery
  
Box of AstraZeneca COVID-19 vaccine
The US FDA could use data on the AstraZeneca COVID-19 vaccine to inform its review of rare blood clots seen with the Janssen vaccine. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet